Purchase Order 75D30124P19215

Award Date 9/1/24
Potential Completion Date 10/7/24
Potential Value $20K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order to Life Technologies Corporation for the procurement of two QuantStudio 5Dx Real-Time Polymerase Chain Reaction (PCR) Systems and associated accessories. The contract has a ceiling value of $121,206.26 and a completion date of August 20, 2024. This is a commercial item acquisition conducted under Simplified Acquisition Procedures and is not a set-aside. Life Technologies Corporation is a manufacturer...
The Centers for Disease Control and Prevention (CDC) awarded an $81,152.68 firm fixed price purchase order to Life Technologies Corporation for the acquisition of QuantStudio 7 Pro real-time polymerase chain reaction (PCR) systems. As the prime contractor, Life Technologies Corporation will deliver the requested PCR systems to the CDC location in Chamblee, Georgia within the period of performance of September 28, 2023 through November 15, 2023. The funding for this contract was provided by the...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $70,428.08 contract is for the provision of a QuantStudio QS7ProDx 96 0.2mL block system, a commercial item that will support the CDC's Parasitic Diseases Branch. This requirement was solicited as a combined synopsis/solicitation under Simplified Acquisition Procedures, with no...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $79,796.08 firm-fixed-price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the purchase of a QIAGEN EZ2 Connect MDX system. This equipment will support the CDC's biomedical research, public health, and healthcare programs. Qiagen has provided a range of laboratory products and services to various federal agencies in the past, including the Department of Health...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer, to provide reagents and consumables. The $184,454.73 contract was awarded on May 12, 2020 and has a completion date of December 24, 2020. No set-aside designation was used. Ortho-Clinical Diagnostics has provided a wide range of diagnostic solutions, including COVID-19 testing...
This is a $94,249.95 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of QS5 PCR instrumentation and is not associated with a set-aside program. Life Technologies has previously served as a prime contractor and subcontractor across various federal agencies, including the National Institutes of Health,...
This definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to purchase reagents and consumables for approximately $59,500. The CDC, a component of the Department of Health and Human Services, seeks to protect public health and safety through the control and prevention of disease, injury, and disability. This firm fixed price contract supports the CDC's mission and is being performed in Chamblee, Georgia through August 1, 2023. No set...
The Centers for Disease Control and Prevention (CDC) awarded a $50,613 purchase order contract to Qiagen, LLC to provide products and services in support of the agency's public health programs. As a subsidiary of Qiagen N.V., Qiagen will deliver items from its product catalog to the CDC location in Germantown, Maryland under a firm fixed price arrangement. No additional details were provided on the scope of work. The award draws from the CDC's annual appropriations and advances the agency's...
Quidel Corporation, doing business as Quidel and located in San Diego, California, has been awarded a $271,980.26 firm fixed-price purchase order contract from the Centers for Disease Control and Prevention to provide QuickVue SARS Antigen Assays. As a manufacturer of medical diagnostics and point-of-care solutions, Quidel will deliver rapid COVID-19 antigen test kits from its San Diego facilities to support the Department of Health and Human Services' pandemic response efforts. No set-aside...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $82,823.10 firm fixed price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the EZ2 CONNECT MDX SYSTEM FUL-3. This system supports the CDC's biomedical research, public health, and healthcare programs. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. The contract has no set-aside designation and is scheduled for completion by...

The Centers for Disease Control and Prevention (CDC) has awarded a firm-fixed-price purchase order to Quidelortho Corporation for the procurement of a VITROS 3600 System. The contract has a ceiling value of $20,000.00 and a period of performance through October 7, 2024. This requirement falls under NAICS code 334516 - Research and Development in the Physical, Engineering, and Life Sciences. The award was made without the use of a set-aside. The place of performance is Chamblee, Georgia. The original solicitation notice indicated that the CDC intended to issue this sole-source order to Quidelortho Corporation, and invited interested parties to submit capabilities statements and pricing information to potentially compete the requirement, but a competitive procurement was not conducted.

Generated 10/8/24, 9:21 AM